Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
Clinical trial NCT01412034 · COMPLETED
Trial details
- NCT number
- NCT01412034
- Sponsor
- Cerenis Therapeutics, SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.